Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 4/20 | 0.68 |
| ▸ | CTSB | P07858 | 3/20 | 0.68 |
| ▸ | CTSS | P25774 | 2/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25295713 | 1.00 | CTSL (0.68) | CTSLCTSBCTSS | |
| SCHEMBL7414175 | 0.89 | CTSL (0.67) | CTSLCTSBCTSS | |
| SCHEMBL7414172 | 0.89 | CTSL (0.67) | CTSLCTSBCTSS | |
| SCHEMBL23752592 | 0.85 | CTSL (0.58) | CTSLCTSBCTSS | |
| SCHEMBL8691322 | 0.85 | CTSL (0.62) | CTSLCTSBCTSS | |
| SCHEMBL8691324 | 0.85 | CTSL (0.62) | CTSLCTSBCTSS | |
| K-777 SCHEMBL25247156 | 0.81 | CTSL (1.00) | CTSLCTSBCTSS | |
| K-777 SCHEMBL6267778 | 0.81 | CTSL (1.00) | CTSLCTSBCTSS | |
| K-777 SCHEMBL25290266 | 0.81 | CTSL (1.00) | CTSLCTSBCTSS | |
| SCHEMBL7028122 | 0.79 | CTSL (0.78) | CTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301988-A1 | INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF | THE TEXAS A&M UNIVERSITY SYSTEM | 2023-09-28 | — | — | US | disclosed |
| EP-4203957-A2 | INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF | The Texas A&M University System (US) | 2023-07-05 | — | — | EP | disclosed |
| WO-2022047054-A2 | INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2022-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230301988-A1 | INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF | CTSV, ACE2, CTSL | CTSL 3/4885CTSB 7/4885CTSS 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.